From Our Thought Leader's

Sartorius Welcomes Dr. Florian Funck as CFO and Executive Board Member

  Dr. Funck brings a wealth of experience and expertise to his new role. Having studied business administration at the prestigious University of Münster, he further solidified his knowledge by earning his doctorate. His journey to this piv... Read more

03 April, 2024 | Wednesday | News
Nurturing Sustainability in Life Sciences: A Dialogue with Ryan Walker, Sustainability Programme Leader at Cytiva

  Cytiva shines as a model of sustainable principles in the dynamic field of life sciences, where pioneering innovation intersects with societal responsibility.At the forefront of their sustainability endeavours is Ryan Walker, the Programme Le... Read more

26 March, 2024 | Tuesday | Interaction
Positive CHMP Opinions for Bempedoic Acid and Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet

    “We are thrilled with the positive CHMP opinion, which reflects the significant cardiovascular risk reduction benefit that the bempedoic acid global franchise brings to patients worldwide,” said Sheldon Koenig, President a... Read more

25 March, 2024 | Monday | News
BIO Sets New Strategic Direction on National Security Under Leadership of CEO John F. Crowley

    Why Biotech is a National Security Imperative John F. Crowley, stepping into his role as BIO's President and CEO, emphasized the critical role of biotechnology as a national security cornerstone. On March 13, ... Read more

15 March, 2024 | Friday | Reports

Bio Finance

Johnson & Johnson Sounds Alarm on TRC Capital Investment's Below-Market Mini-Tender Offer for Company Shares

Johnson & Johnson announced that it has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation of Ontario, Canada to purchase up to 1 million shares of Johnson & Johnson common stock at a price of $151.23 pe... Read more

05 April, 2024 | Friday | News
EnteroBiotix Completes £27 Million Funding Round to Advance Microbiome Therapeutics for Gut Disorders

EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics,  announced that the Company has completed its £27m ($34m USD) funding round, supported by new and exis... Read more

04 April, 2024 | Thursday | News

Contract Services

FibroBiologics Secures Australian Patent for Breakthrough Cartilage Regeneration Method

FibroBiologics, , a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced the i... Read more

12 April, 2024 | Friday | News
Blue Wolf Capital Partners to Acquire Seven European Manufacturing and Development Facilities from Recipharm

    The facilities, located in Solna, Stängnäs, Höganäs, Karlskoga, and Uppsala OTC Development in Sweden, Pessac in France, and Parets in Spain, have been integral parts of Recipharm for over a decade. Specializing in... Read more

03 April, 2024 | Wednesday | News

BioPharma Video

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close